Targeting tumors with antibody-based therapeutics is a complex task presenting multiple kinetic barriers. Antibody internalization and clearance inhibit uptake both in solid tumors, limited by tu-mor vascular permeability, and in micrometastases, limited by diffusion. Methods: A modeling exercise is used to introduce 2 simple criteria that must be less than unity for saturation of both tumors and micrometastases. The clearance modulus and the Thiele modulus are ratios of the plasma clearance rate and antibody catabolism, respectively, to the tumor tissue pene-tration rate. Results: Even low rates of antigen internalization from constitutive membrane turnover can significantly retard an-tibody penetration. Rapid clearance of single-chain var...
The major problem of tumour radioimmunotherapy remains the low tumour antibody uptake and this leads...
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The mod...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, February 2013...
Targeting tumors with antibody-based therapeutics is a complex task presenting multiple kinetic barr...
Antibodies are under development to treat a variety of cancers, such as lymphomas, colon, and breast...
The use of antibody-based therapeutics has proven very promising for clinical applications in cancer...
The use of antibody-based therapeutics has proven very promising for clinical applications in cancer...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2008.Vita.Inc...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, February 20...
With the decreasing cost of monoclonal antibody production, radioimmunotherapy (RIT) has rapidly eme...
Despite the significant resources dedicated to the development of monoclonal antibody (mAb) therapie...
Monoclonal antibodies (mAbs) have become a cornerstone in the therapeutic guidelines of a wide range...
<div><p>The ability to use a systemically injected agent to image tumor is influenced by tumor chara...
With the decreasing cost of monoclonal antibody production, radioimmunotherapy (RIT) has rapidly eme...
A nonlinear compartmental model has been developed to optimise tumour targeting using radiolabelled ...
The major problem of tumour radioimmunotherapy remains the low tumour antibody uptake and this leads...
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The mod...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, February 2013...
Targeting tumors with antibody-based therapeutics is a complex task presenting multiple kinetic barr...
Antibodies are under development to treat a variety of cancers, such as lymphomas, colon, and breast...
The use of antibody-based therapeutics has proven very promising for clinical applications in cancer...
The use of antibody-based therapeutics has proven very promising for clinical applications in cancer...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, 2008.Vita.Inc...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Biological Engineering, February 20...
With the decreasing cost of monoclonal antibody production, radioimmunotherapy (RIT) has rapidly eme...
Despite the significant resources dedicated to the development of monoclonal antibody (mAb) therapie...
Monoclonal antibodies (mAbs) have become a cornerstone in the therapeutic guidelines of a wide range...
<div><p>The ability to use a systemically injected agent to image tumor is influenced by tumor chara...
With the decreasing cost of monoclonal antibody production, radioimmunotherapy (RIT) has rapidly eme...
A nonlinear compartmental model has been developed to optimise tumour targeting using radiolabelled ...
The major problem of tumour radioimmunotherapy remains the low tumour antibody uptake and this leads...
A mathematical model has been developed to optimize tumor targeting with labeled antibodies. The mod...
Thesis (Ph. D.)--Massachusetts Institute of Technology, Dept. of Chemical Engineering, February 2013...